Active Ingredient(s):Hydroxyurea FDA Approved: * December 7, 1967 Pharm Company: *BRISTOL MYERS SQUIBB Category:HIV / AIDS
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, essential thrombocythemia, chronic myelogenous leukemia and cervical cancer. In sickle-cell disease it increases fetal hemoglobin and decreases the number of attacks. It is taken by mouth.
Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches....
* May have multiple approval dates, manufacturers, or labelers.